Johannes Notni

30PUBLICATIONS
24CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersProteins and peptidesAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 27, 2026
Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer.

|Dec 07, 2025
Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair.

Jan Wuestemann, Elisabeth Eppard, Daniel Hescheler

|Jun 20, 2025
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression.

Kateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová

|Nov 28, 2024
Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted 177Lu-Labeled Cancer Theranostics.

Tim Rheinfrank, Viktor Lebruška, Stefan Stangl

|Jun 24, 2024
The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics.

Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig

|May 08, 2024
Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles.

Stefan Stangl, Nghia Trong Nguyen, Julia Brosch-Lenz

Pageof 5

Frequent Collaborators

3 joint publications

Luciana Marinelli

3 joint publications

Horst Kessler

3 joint publications

Vojtěch Kubíček

2 joint publications

Jan Kotek